GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments

Date:




The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Cooler, drier Sunday before another around of light precipitation tomorrow

Happy Sunday! The coldest air of the fall season...

The mythic origin of Chilean sea bass

It's a fish that underwent a rebranding in the...

Vince Gill Predicts Ella’s ‘Choosin’ Texas’ Will Become Timeless

Ella Langley undoubtedly struck country music gold with her...